Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07218952Enrolling by invitation
Radiation therapy for Parkinson's disease
This trial tests if a targeted radiation therapy can help people with early-stage Parkinson's disease that affects only one side of the body. It aims to see if this treatment can slow down the disease and improve symptoms.
Rochester, MinnesotaAges 45–70 - NCT07215871Enrolling by invitationPhase 1
Second H10N7 flu challenge for prior participants
This study tests whether people who have already been exposed to a lab-made H10N7 flu virus can be safely exposed again. It checks how their immune system responds and how long they shed the virus, in a controlled, isolated setting.
Bethesda, MarylandAges 18–55 - NCT07181135Enrolling by invitationPhase 3
Finerenone for kidney disease without certain blood pressure drugs
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
BarcelonaAges 18 years+ - NCT07171957Enrolling by invitation
Motor imagery for chronic obstructive pulmonary disease
This trial studies whether practicing motor imagery (imagining movements without actually doing them) can help people with COPD improve their breathing and daily function. It may offer a new way to manage symptoms without physical exercise.
KütahyaAges 40–70 - NCT07165626Enrolling by invitation
Retina measurements after epiretinal membrane removal surgery
This study checks how the retina changes after surgery to remove a wrinkled layer (epiretinal membrane). It's for people who already have had cataract surgery and are having the membrane removed because their vision is warped or blurry.
SzczecinAges 18–80 - NCT07162688Enrolling by invitationPhase 1/Phase 2
Omega-3 fatty acids to prevent graft-versus-host disease after stem cell transplant
This trial tests whether omega-3 fatty acids can help prevent acute graft-versus-host disease (aGVHD) in people receiving a stem cell transplant from a donor. Omega-3 may reduce inflammation and lower the chance of this serious complication.
Fuzhou, FujianAges 18–65 - NCT07159581Enrolling by invitation
Gene therapy for Wilson disease study with PET scans
This trial uses a special PET scan with a copper tracer to see how well gene therapy is working in people with Wilson disease. It may help doctors understand if the treatment is helping your body handle copper properly.
Aarhus, Aarhus NAges 18 years+ - NCT07144202Enrolling by invitation
Long-term protection study after EV71 vaccination
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
Guilin, GuangxiAges Any age - NCT07130955Enrolling by invitation
Ablation for hard-to-control high blood pressure with kidney disease
This study tests a new device that uses energy to calm kidney nerves, which may help lower blood pressure in people with chronic kidney disease whose blood pressure stays high despite taking multiple medications.
Beijing, Beijing MunicipalityAges 18–65 - NCT07122323Enrolling by invitation
Robot-assisted hip replacement for Legg-Calve-Perthes disease
This trial compares robot-assisted total hip replacement to the usual surgery for people with Legg-Calve-Perthes disease. It aims to see if the robotic arm helps the surgery go more smoothly.
Hangzhou, ZhejiangAges 18–80 - NCT07117201Enrolling by invitation
Produce prescription for chronic disease management
This trial gives free fruits and vegetables to help manage chronic conditions like high blood pressure, diabetes, and obesity. You'll attend team visits to learn about healthy eating and track your progress.
Richmond, VirginiaAges 18 years+ - NCT07110389Enrolling by invitation
Heart health app program for coronary disease
This study tests a home-based cardiac rehabilitation program delivered through a smartphone app for people with coronary heart disease. If you join, you'll use the app to track your health and get support, which may help you recover and stay heart-healthy.
Taoyuan, Guishan Dist.Ages 20 years+ - NCT07102667Enrolling by invitation
Protein intake for muscle health in older kidney patients
This study tests how much protein older adults with kidney disease and muscle loss should eat to build or maintain muscle. You will follow a protein plan and do simple resistance exercises to see if it helps your strength.
BangkokAges 65 years+ - NCT07072676Enrolling by invitation
Can a walker help prevent falls in neuromuscular disease?
This study tests if using assistive walking devices, after a short training period, can lower the risk of falls in people with neuromuscular diseases. It aims to help you stay steady and safe on your feet.
Bad FeilnbachAges 65–65 - NCT07036614Enrolling by invitation
New light tool for airway exams
This trial tests a special light device used during a lung airway exam (bronchoscopy) to help doctors see and biopsy growths more clearly. It might help people who are already scheduled for a bronchoscopy because of a spot on their chest x-ray or CT scan.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07033676Enrolling by invitation
Study of a blood marker for heart damage from high blood pressure
This trial looks at a substance in your blood called miR-455-5p to see if it can help doctors understand heart changes caused by high blood pressure. It involves people who have had high blood pressure for over a year and may have some heart symptoms.
Shenzhen, GuangdongAges 18 years+ - NCT07023965Enrolling by invitation
Long-term follow-up study for gene therapy in critical limb ischemia
This study follows up with people who previously took part in a clinical trial testing an experimental gene therapy for critical limb ischemia (severe leg pain or sores due to blocked arteries). It aims to see how well the treatment works over time. If you were in that earlier trial and received at least one dose, joining this follow-up could help researchers learn more about the therapy's lasting effects.
Beijing, Beijing MunicipalityAges 20–85 - NCT06999330Enrolling by invitation
TMS for anxiety in Parkinson's disease
This study tests whether transcranial magnetic stimulation (TMS), a non-invasive brain treatment, can help reduce anxiety in people with Parkinson's disease. You may qualify if you have both Parkinson's and significant anxiety symptoms.
Saint Paul, MinnesotaAges 40–90 - NCT06992284Enrolling by invitation
Heart disease study in Niigata
This study looks at the long-term outlook for people with heart disease in Niigata, Japan. It helps doctors learn more about what affects recovery and health over time.
Niigata, NiigataAges 18 years+ - NCT06963879Enrolling by invitation
Video game test and treatment for Alzheimer's disease
This study uses interactive video games to help diagnose and potentially treat early-stage Alzheimer's disease or mild cognitive impairment. It is testing whether these games can improve thinking skills.
Mataró, BarcelonaAges 50 years+ - NCT06960005Enrolling by invitation
Exercise to improve muscle and reduce falls in thyroid disease
This study tests whether a special exercise program can help older women with thyroid disease improve muscle strength, quality of life, and reduce falls. You would do supervised rhythm-based multitask exercises (like stepping and moving to music) several times a week.
GistrupAges 65 years+ - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT06958042Enrolling by invitation
Lung and bladder health study for COPD patients
This study looks at how common bladder problems are in people with stable COPD. It aims to help doctors better understand and manage these symptoms.
Kütahya, CenterAges 40–65 - NCT06951451Enrolling by invitation
Smartphone app to improve heart medication use in Oman
This study tests whether a smartphone app called MED-AD helps people in Oman with heart conditions take their medications more regularly. If you join, you'll use the app and the researchers will compare your medication habits to those who don't use it.
MuscatAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.